As of today (2026-07-06), the Forward Annual Dividend Yield of TTK Healthcare is 1.09%.
As of today (2026-07-06), the Trailing Annual Dividend Yield of TTK Healthcare is 1.09%.
BOM:507747's Forward Dividend Yield % is ranked worse than 69.43% of 507
companies
in the Drug Manufacturers industry
Industry Median: 2.03
vs BOM:507747: 1.09
During the past 5 years, the average Dividends Per Share Growth Rate was 24.10% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 9.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of TTK Healthcare was 49.40% per year. The lowest was -15.70% per year. And the median was 7.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
TTK Healthcare Forward Dividend Yield % Related Terms
BOM:507747 vs LLY, JNJ, ABBV: Forward Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, TTK Healthcare's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TTK Healthcare Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where TTK Healthcare's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
TTK Healthcare Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 10.000000
2025-07-18
2025-07-19
2025-08-04
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
TTK Healthcare's Forward Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 1.09% mean?
TTK Healthcare (BOM:507747) has a Forward Dividend Yield % of 1.09% as of Jul. 06, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on TTK Healthcare and its competitors. According to the industry distribution chart, TTK Healthcare ranks #352 out of 507 companies in the Drug Manufacturers industry, placing it in the top 69.4%.
Is TTK Healthcare's Forward Dividend Yield % too high?
TTK Healthcare's current Forward Dividend Yield % is 1.09%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.03. TTK Healthcare's value of 1.09% is 46.3% below this industry median. Based on the distribution chart, TTK Healthcare ranks #352 out of 507 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, TTK Healthcare has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TTK Healthcare's Forward Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, TTK Healthcare ranks #352 out of 507 companies for Forward Dividend Yield %. This places TTK Healthcare in the lower half of its industry. The industry median Forward Dividend Yield % is 2.03. TTK Healthcare's value of 1.09% is 46.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.03, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TTK Healthcare's current Forward Dividend Yield % of 1.09% is 46.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on TTK Healthcare and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TTK Healthcare's current Forward Dividend Yield % is 1.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TTK Healthcare stock overvalued right now?
Based on GuruFocus' analysis, TTK Healthcare (BOM:507747) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,452.98, compared to a current price of ₹920.00 — trading 36.7% below its estimated fair value. The current Forward Dividend Yield % is 1.09% and 46.3% below the Drug Manufacturers industry median of 2.03. TTK Healthcare's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For TTK Healthcare (BOM:507747), the current Forward Dividend Yield % is 1.09% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TTK Healthcare (BOM:507747) Overvalued in 2026?
Based on GuruFocus' analysis, TTK Healthcare stock appears to be undervalued.
The current stock price of ₹920.00 is trading 36.7% below its estimated GF Value™ of ₹1,452.98.
GuruFocus considers TTK Healthcare to be Significantly Undervalued.
Key valuation signals for BOM:507747:
Forward Dividend Yield %: 1.09%
GF Value™: ₹1,452.98 vs. price of ₹920.00 (36.7% below fair value)
Industry Position: 46.3% below the Drug Manufacturers median (#352 of 507)
No single metric tells the full story. See the BOM:507747 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.
77GF Score
Get the complete analysis for BOM:507747
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:507747 has been successfully added to your 